Novel and potent catalytic approach that directly clears amyloid on the inside of neurons as well as reduces amyloid plaques with the potential to be superior to monoclonal antibodies and restore ...
A new chapter is unfolding for gene therapies in Europe. With retinal programs advancing into Phase I/II trials and ...
It's well known that many animals, including migratory birds, butterflies, and even fish, use the sun for navigational purposes. Nocturnal animals are dealt a more difficult hand, however, as the moon ...
Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...
A silent revolution is unfolding inside Indian laboratories. From the patent-free power of an indigenous CRISPR tool to ...
ScienceAlert on MSN
One Key Protein Could Be a Powerful New Target Against Malaria
The Anopheles stephensi mosquito is a known vector for malaria. (Jim Gathany/CDC/public domain) Malaria killed about 610,000 people globally in 2024, with most deaths occurring in Africa, where young ...
Recent transactions make clear that large pharmaceutical companies now view rare disease as a core area for sustained growth, rather than episodic deal-making. BioMarin’s acquisition of Amicus ...
Warmer-than-average temperatures and recent rainfall across the Las Vegas Valley have prompted the Southern Nevada Health ...
In exploring barriers in rare disease research and drug development, experts highlight a lack of robust models, limited trial populations, fragmented global expectations, and production bottlenecks as ...
As this refinery has defied the odds and become a global success story and a reformer of the Nigerian economy in many respects, its robustness to withstand perturbations that threaten corporate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results